DRMA
$1.22
Pre-MarketAs of Mar 17, 8:00 PM UTC
Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications.
Intraday
Custom Range:to
No data available for this range. Intraday data may be limited by the exchange.
Recent News
No recent news found.